GlassScriptPhysician profile
Anuj K Agarwal
NPI 1598298614
$2,078.03
in general payments reported to CMS, 2019-2025
13 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $114 · 2022: $104 · 2024: $1,472 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,247 · Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,246.96 |
| Food and Beverage | $366.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,360.76 | 2024 | Single Use Suction Valve (Sterile) |
| E.R. Squibb & Sons, L.L.C. | $246.21 | 2019 | |
| Genzyme Corporation | $114.24 | 2020 | |
| Saluda Medical Americas, INC. | $80.65 | 2024 | Evoke |
| Cardiva Medical, INC. | $77.91 | 2022 | |
| United Therapeutics Corporation | $49.24 | 2025 | Tyvaso, Orenitram |
| Merck Sharp & Dohme LLC | $32.13 | 2025 | Zerbaxa |
| Pharmacosmos Therapeutics INC. | $26.41 | 2022 | |
| Verona Pharma, INC. | $24.49 | 2025 | Ohtuvayre |
| Astrazeneca Pharmaceuticals LP | $20.66 | 2025 | |
| Abbvie INC. | $16.63 | 2024 | |
| Viatris Specialty LLC | $15.07 | 2025 | Yupelri |
| Aurinia Pharma U.S., INC. | $13.63 | 2024 | Lupkynis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.